Genome-wide CRISPR activation screen identifies novel receptors for SARS-CoV-2 entry

Zhu, Shiyou; Liu, Ying; Zhou, Zhuo; Zhang, Zhiying; Xiao, Xia; Liu, Zhiheng; Chen, Ang; Dong, Xiaojing; Tian, Feng; Chen, Shihua; Xu, Yiyuan; Wang, Chunhui; Li, Qiheng; Niu, Xuran; Pan, Qian; Du, Shuo; Xiao, Junyu; Wang, Jianwei; Wei, Wensheng

The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been endangering worldwide public health and economy. SARS-CoV-2 infects a variety of tissues where the known receptor ACE2 is low or almost absent, suggesting the existence of alternative pathways for virus entry. Here, we performed a genome-wide barcoded-CRISPRa screen to identify novel host factors that enable SARS-CoV-2 infection. In addition to known host proteins, i.e. ACE2, TMPRSS2 and NRP1, we identified multiple host components, among which LDLRAD3, TMEM30A and CLEC4G were confirmed as functional receptors for SARS-CoV-2. All these membrane proteins bind directly to spike’s N-terminal domain (NTD). Their essential and physiological roles have all been confirmed in either neuron or liver cells. In particular, LDLRAD3 and CLEC4G mediate SARS-CoV-2 entry and infection in a fashion independent of ACE2. The identification of the novel receptors and entry mechanisms could advance our understanding of the multiorgan tropism of SARS-CoV-2, and may shed light on the development of the therapeutic countermeasures against COVID-19.